Skip to content

Clinical trials

Completed Lymphoma, Large B-Cell, Diffuse trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Completed Country / region: Austria Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20092
20102
20112
20121
20152
20161
20173
20183
20193
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Arbeitsgemeinschaft medikamentoese Tumortherapie3
Celgene3
Hoffmann-La Roche2
MorphoSys AG2
Regeneron Pharmaceuticals2
CTI BioPharma1
GWT-TUD GmbH1
GlaxoSmithKline1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse26
Lymphoma, Non-Hodgkin8
Recurrence6
Lymphoma5
Lymphoma, Follicular5
Lymphoma, B-Cell4
Dendritic Cell Sarcoma, Interdigitating2
Burkitt Lymphoma1
Hematologic Neoplasms1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.